Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mindset Pharma Inc. (MSET.CN)

Mindset Pharma Inc. (MSET.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 33,732
  • Shares Outstanding, K 66,141
  • Annual Sales, $ 0 K
  • Annual Income, $ -33 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.10
Trade MSET.CN with:
  • Price/Earnings ttm 314.23
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings -0.03 on 12/31/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.410 +24.39%
on 04/16/21
0.850 -40.00%
on 03/24/21
-0.340 (-40.00%)
since 03/19/21
3-Month
0.410 +24.39%
on 04/16/21
1.550 -67.10%
on 02/19/21
-0.340 (-40.00%)
since 01/20/21

Most Recent Stories

More News
Mindset Pharma Announces Strong Confirmation of In Vivo Proof-of-Concept Across Its Entire New Drug Program Portfolio

Toronto, Ontario--(Newsfile Corp. - April 20, 2021) - (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("" or the "") is pleased to announce, that based on data derived from Mindset's testing program (i.e. testing...

MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceeds of $1.052 Million

Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("" or the "") is pleased to announce that in connection with its previously announced "bought deal" public offering...

MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering

Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("" or the "") is pleased to announce that it has completed the previously announced "bought deal" public offering...

MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
Mindset Pharma Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended December 31, 2020

Toronto, Ontario--(Newsfile Corp. - April 1, 2021) - (CSE: MSET) (OTCQB: MSSTF) (FSE: 9DF)("" or the "") - Mindset announces that it has refiled its interim financial statements for the three and six month...

MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
Mindset Pharma Expands Scientific Team: Dr. Malik Slassi Appointed Senior VP Innovation and Ian Dean Appointed Director Preclinical Development

Toronto, Ontario--(Newsfile Corp. - March 30, 2021) - (CSE: MSET) (OTCQB: MSSTF) (FSE: 9DF)("" or the ""), a drug discovery and development company focused on developing next generation psilocybin and...

TRIL : 9.23 (-4.15%)
MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics Evaluation Platform ("Cope"); Cope Expected to Be World's First in Vivo Psychedelic Benchmark Data Set

Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF)("" or the ""), a biotechnology company focused on developing next generation psychedelic medicines and related...

MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
InterVivo Solutions and Mindset Pharma to Jointly Develop Advanced Cooperative Psychedelics Evaluation Platform ("COPE")

Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - InterVivo Solutions Inc. ("InterVivo" or "IVS" or the "Company"), a leading Canadian contract research organization providing preclinical research...

MSET.CN : 0.510 (+10.87%)
Mindset Pharma Announces Upsize of Bought Deal to $7.5 Million

Mindset Pharma Announces Upsize of Bought Deal to $7.5 Million

MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
Mindset Pharma Announces $5 Million Bought Deal Financing

Mindset Pharma Announces $5 Million Bought Deal Financing

MSET.CN : 0.510 (+10.87%)
MSSTF : 0.3550 (-4.05%)
More People Are Turning to Psychedelics to Treat Mental Health Issues

Psychedelic treatments could revolutionize the way millions are treated for mental health issues. So ...

PSYCF : 0.1825 (-7.45%)
MSSTF : 0.3550 (-4.05%)
MYCOF : 0.2750 (+1.18%)
NUMI.VN : 0.830 (-7.78%)
LKYSF : 0.6500 (-9.47%)
TRYP.CN : 0.600 (-3.23%)
MSET.CN : 0.510 (+10.87%)
MYCO.CN : 0.400 (-6.98%)
PSYC.CN : 0.225 (-8.16%)

Key Turning Points

3rd Resistance Point 0.667
2nd Resistance Point 0.603
1st Resistance Point 0.557
Last Price 0.510
1st Support Level 0.447
2nd Support Level 0.383
3rd Support Level 0.337

See More

52-Week High 2.200
Fibonacci 61.8% 1.516
Fibonacci 50% 1.305
Fibonacci 38.2% 1.094
Last Price 0.510
52-Week Low 0.410

See More

Business Summary

Mindset Pharma Inc is a drug discovery and development company focused on creating psychedelic medicines to treat neurological and psychiatric disorders.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar